Back
Xeris Biopharma Holdings Vs. Dave Industry Stock Comparison
Buy
88
XERS
Xeris Biopharma Holdings
Last Price:
3.37
Seasonality Move:
0.46%
Buy
79
DAVE
Dave
Last Price:
45.41
Seasonality Move:
103.59%
Buy
88
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $3.34. The Score for XERS is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
79
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $45.87. The Score for DAVE is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $3.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 73.05 | Buy |
| Chaikin Money Flow: | 634179 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.93 - 3.23) | Buy |
| Bollinger Bands (100): | (2.32 - 3.02) | Buy |
DAVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 62.43 | Buy |
| Chaikin Money Flow: | 1584842 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.77 - 44.59) | Buy |
| Bollinger Bands (100): | (33.52 - 41.52) | Buy |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.25 | Buy |
| 20-day SMA: | 3.12 | Buy |
| 50-day SMA: | 2.94 | Buy |
| 200-day SMA: | 2.47 | Buy |
| 8-day EMA: | 3.24 | Buy |
| 20-day EMA: | 3.14 | Buy |
| 50-day EMA: | 2.96 | Buy |
| 200-day EMA: | 2.54 | Buy |
DAVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.53 | Buy |
| 20-day SMA: | 41.58 | Buy |
| 50-day SMA: | 39.74 | Buy |
| 200-day SMA: | 36.11 | Buy |
| 8-day EMA: | 40.41 | Buy |
| 20-day EMA: | 40.66 | Buy |
| 50-day EMA: | 39.93 | Buy |
| 200-day EMA: | 34.24 | Buy |
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.15 per share.
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.60 per share.
Xeris Biopharma Holdings Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dave Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||